NTRK1 and cancer: Whole exome sequencing data from 9125 tumors profiled by The Cancer Genome Atlas (TCGA) indicate that the most commonly disrupted pathways in cancer are the receptor tyrosine kinase/Ras pathway, cell cycle, and PI3K pathways [29].